We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
+19.44%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$1.11B
AUM Growth
+$33.3M
(+3.1%)
Cap. Flow
-$6.36M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
54.13%
Holding
78
New
4
Increased
24
Reduced
16
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Orthofix Medical
OFIX
|
+$51.9M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$15.1M |
| 3 |
FNA
Paragon 28, Inc.
FNA
|
+$14.3M |
| 4 |
OptimizeRx
OPRX
|
+$10.9M |
| 5 |
Pliant Therapeutics
PLRX
|
+$10.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
|
+$57.4M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$27.9M |
| 3 |
Krystal Biotech
KRYS
|
+$21.8M |
| 4 |
MODN
MODEL N, INC.
MODN
|
+$15.6M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$15.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.41% |
| 2 | Communication Services | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
OptimizeRx
OPRX
$142M
| $14.8M | 1.33% |
1,010,931
+649,655
| +180% | +$10.9M |
|
|
CUTR
27
DELISTED
Cutera, Inc.
CUTR
| $13.5M | 1.21% |
569,868
+2,729
| +0.5% | +$87.2K |
|
28
OrthoPediatrics
KIDS
$607M
| $13.4M | 1.2% |
301,579
-1,152
| -0.4% | -$50.9K |
|
29
Insmed
INSM
$26.2B
| $12.8M | 1.15% |
750,883
+1,913
| +0.3% | +$37.2K |
|
30
Tactile Systems Technology
TCMD
$510M
| $11.5M | 1.03% |
+700,000
| New | +$9.75M |
|
|
SCTL
31
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $10.6M | 0.96% |
8,916,870
+345,000
| +4% | +$454K |
|
32
Xenon Pharmaceuticals
XENE
$5.45B
| $10M | 0.9% |
+279,444
| New | +$10.3M |
|
33
Ultragenyx Pharmaceutical
RARE
$1.29B
| $9.45M | 0.85% |
235,777
+1,478
| +0.6% | +$63.4K |
|
|
SONX
34
DELISTED
Sonendo, Inc.
SONX
| $8.37M | 0.75% |
4,185,619
| – | – |
|
35
MaxCyte
MXCT
$123M
| $6.75M | 0.61% |
1,364,222
-1,121
| -0.1% | -$5.52K |
|
36
Genmab
GMAB
$21B
| $6.04M | 0.54% |
160,025
-238
| -0.1% | -$9.15K |
|
37
BioMarin Pharmaceuticals
BMRN
$12.5B
| $5.98M | 0.54% |
61,482
-59,459
| -49% | -$6.16M |
|
38
Pfizer
PFE
$157B
| $5.78M | 0.52% |
141,547
-214
| -0.2% | -$9.24K |
|
|
ABCM
39
DELISTED
Abcam PLC
ABCM
| $5.11M | 0.46% |
379,711
+77
| +0% | +$1.15K |
|
40
Guardant Health
GH
$23.6B
| $4.8M | 0.43% |
204,845
+41
| +0% | +$1.17K |
|
|
MIRO
41
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $3.75M | 0.34% |
2,234,656
+1,700,000
| +318% | +$4.42M |
|
42
Castle Biosciences
CSTL
$1.08B
| $3.67M | 0.33% |
161,618
+14
| +0% | +$342 |
|
43
Stevanato
STVN
$5.88B
| $2.99M | 0.27% |
+115,356
| New | +$2.47M |
|
|
AKU
44
DELISTED
Akumin Inc
AKU
| $2.41M | 0.22% |
3,539,498
-24,766
| -0.7% | -$24.4K |
|
45
Simulations Plus
SLP
$372M
| $1.57M | 0.14% |
35,703
-50
| -0.1% | -$2K |
|
46
Humana
HUM
$47.6B
| $431K | 0.04% |
888
| – | – |
|
47
Takeda Pharmaceutical
TAK
$59.7B
| $422K | 0.04% |
25,630
| – | – |
|
48
Smith & Nephew
SNN
$11.7B
| $422K | 0.04% |
15,111
| – | – |
|
49
Sanofi
SNY
$102B
| $420K | 0.04% |
7,711
| – | – |
|
50
Integra LifeSciences
IART
$1.22B
| $417K | 0.04% |
7,261
| – | – |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, First Light Asset Management held 78 positions worth $1.11B, up 3.1% from $1.08B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Light Asset Management's Q1 2023 filing shows 4 new, 24 increased, 16 reduced and 4 closed positions. Its largest new stake was Orthofix Medical: 2,650,971 shares worth $44.4M. The largest sale was SeaSpine Holdings Corporation Common Stock, an estimated $57.4M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 91% a quarter earlier, followed by Communication Services.
- First Light Asset Management's largest Q1 2023 buy was Orthofix Medical: 2,650,971 shares worth $44.4M.
- First Light Asset Management added most to Karuna Therapeutics, Inc. Common Stock in Q1 2023, an estimated $15.1M increase.
- First Light Asset Management's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $27.9M.
- First Light Asset Management fully exited SeaSpine Holdings Corporation Common Stock in Q1 2023, selling an estimated $57.4M.
- First Light Asset Management's ten largest holdings make up 54% of its $1.11B portfolio in Q1 2023.
- First Light Asset Management opened 4 new positions and closed 4 in Q1 2023.
- First Light Asset Management's portfolio value rose 3.1% quarter-over-quarter to $1.11B.
Based on First Light Asset Management's 13F filing for Q1 2023, filed 15 May 2023.